Myelofibrosis-associated massive splenomegaly: A cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea

American Journal of Hematology

Volumn 80, Issue 2, 2005, Pages 128-132

  Ziakas, Panayiotis D ^a   Voulgarelis, Michael ^a   Felekouras, Evagelos ^a   Anagnostou, Dimitra ^b   Tzelepis, George E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Dyspnea; Intra abdominal pressure; Myelofibrosis; Splenomegaly

Indexed keywords

ABDOMINAL PRESSURE; ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DYSPNEA; EVALUATION; FEMALE; HEMODYNAMIC MONITORING; HUMAN; HYPOXEMIA; MYELOFIBROSIS; MYELOFIBROSIS WITH MYELOID METAPLASIA; MYELOID METAPLASIA; NON INVASIVE MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPLENOMEGALY;

ABDOMEN; ANOXEMIA; DYSPNEA; FEMALE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; PRESSURE; SPLENOMEGALY;

EID: 26444535768     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20388     Document Type: Article

References (22)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-1265.
2. Tefferi A. The forgotten myeloproliferative disorder: myeloid metaplasia. Oncologist 2003;8:225-231.
3. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001;120:801-808.
4. Garcia-Manero G, Schuster SJ, Patrick H, Martinez J. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol 1999;60:130-135.
5. Kadikoylu G, Onbasili A, Tekten T, Barutca S, Bolaman Z. Functional and morphological cardiac changes in myeloproliferative disorders (clinical study). Int J Cardiol 2004;97:213-220.
6. Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc 2003;78:1223-1233.
7. Weinschenker P, Kutner JM, Salvajoli JV, et al. Whole-pulmonary low-dose radiation therapy in agnogenic myeloid metaplasia with diffuse lung involvement. Am J Hematol 2002;69:277-280.
8. Steensma DP, Hook CC, Stafford SL, Tefferi A. Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia. Br J Haematol 2002;118:813-816.
9. Haznedaroglu IC, Atalar E, Ozturk MA, et al. Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension. Platelets 2002;13:395-399.
10. Ito H, Adachi Y, Arimura Y, Endo T, Hinoda Y, Imai K. A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder. J Gastroenterol 2003;38:488-492.
11. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003;133:163-169.
12. Yang YY, Lin HC, Lee WC, et al. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations. J Gastroenterol 2001;36:181-186.
13. Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997;25:1282-1284.
14. Tzelepis GE, Nasiff L, McCool FD, Hammond J. Transmission of pressure within the abdomen. J Appl Physiol 1996;81:1111-1114.
15. Obeid F, Saba A, Path J, et al. Increases in intra-abdominal pressure affect pulmonary compliance. Arch Surg 1995;130:544-547.
16. Shafik A, El-Sharkawy A, Sharaf WM. Direct measurement of intra-abdominal pressure in various conditions. Eur J Surg 1997;163:883-887.
17. Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 2000;95:2226-2233.
18. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 1997;7:246-248.
19. Windberger UB, Auer R, Keplinger F, et al. The role of intra-abdominal pressure on splanchnic and pulmonary hemodynamic and metabolic changes during carbon dioxide pneumoperitoneum. Gastrointest Endosc 1999;49:84-91.
20. Ridings PC, Bloomfield GL, Blocher CR, Sugerman HJ. Cardiopulmonary effects of raised intra-abdominal pressure before and after intravascular volume expansion. J Trauma 1995;39:1071-1075.
21. Quintel M, Pelosi P, Caironi P, et al. An increase of abdominal pressure increases pulmonary edema in oleic acid-induced lung injury. Am J Respir Crit Care Med 2004;169:534-541.
22. Chang MC, Miller PR, D'Agostino R Jr, Meredith JW. Effects of abdominal decompression on cardiopulmonary function and visceral perfusion in patients with intra-abdominal hypertension. J Trauma 1998;44:440-445.